Melanoma-associated endogenous retrovirus (merv) derived...

Details Melanoma-associated endogenous retrovirus (merv) derived... Melanoma-associated endogenous retrovirus (merv) derived...

A - Human Necessities

61

K

A61K 39/21 (2006.01) A61K 38/16 (2006.01)

Patent

CA 2605006

The present invention provides antigenic polypeptides derived from the melanoma-associated endogenous retrovirus (MERV). These antigens are useful compounds for the detection of cancerous cells and melanoma-diagnosis as well as melanoma-prognosis. Furthermore these antigenic polypeptides of the present invention form the basis for anti-cancer vaccines.

L'invention concerne des polypeptides antigéniques dérivés du rétrovirus endogène associé au mélanome (MERV). Ces antigènes sont des composés utiles pour la détection de cellules cancéreuses, le diagnostic du mélanome et le pronostic du mélanome. Ces polypeptides antigéniques constituent en outre la base de vaccins anticancéreux.

Affiliated with

Also associated with

Rating

Melanoma-associated endogenous retrovirus (merv) derived... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melanoma-associated endogenous retrovirus (merv) derived..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanoma-associated endogenous retrovirus (merv) derived... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1906604